Consistent respirable dose Virtually no drug is lost to the environment Protection from second-hand aerosols
Minimizes medication waste
Efficient treatment times
Biofeedback button confirms actuation and inhalation Reduced Length of Stay and Admission Rates through the ER1
Not Made or Manufactured with BPA, Natural Rubber Latex, Phthalates, Lead, or PVC The AeroEclipse II Breath Actuated Nebulizer (BAN) creates aerosol in response to the patient’s inspiratory flow.
This patient on-demand therapy means less medication waste, higher drug delivery efficiency, and safer clinician working environments. Combining the benefits of breath actuation and superior aerosol particle size, the
AeroEclipse delivers the industry’s most effective respirable dose. Supported by clinical evidence, the AeroEclipse provides approved dosing protocols throughout the hospital and for all patient populations.
